Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Health Care Industry Investment Fund (CHIIF) is a state-level industrial investment fund focused on the healthcare and life sciences sectors in China. Established with the approval of the National Development and Reform Commission (NDRC), the fund invests across the entire healthcare value chain, including pharmaceuticals, medical devices, healthcare services, and biotechnology. CHIIF aims to promote the industrialization of medical research and the consolidation of the Chinese healthcare market through strategic equity investments. The fund typically targets growth-stage and late-stage companies that demonstrate significant technological innovation or market leadership within the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Care Industry Investment Fund.